| 注册
首页|期刊导航|医学信息|坦洛新联合爱普列特治疗良性前列腺增生症的临床观察

坦洛新联合爱普列特治疗良性前列腺增生症的临床观察

张昊

医学信息Issue(20):239-239,1.
医学信息Issue(20):239-239,1.

坦洛新联合爱普列特治疗良性前列腺增生症的临床观察

Epristeride Tamsulosin Combination Treatment of Benign Prostatic Hyperplasia Clinical Observation

张昊1

作者信息

  • 1. 岳阳市三人民医院外一科,湖南 岳阳 414000
  • 折叠

摘要

Abstract

Objective To investigate tamsulosin combination treatment of benign prostatic hyperplasia epristeride ef ectiveness and safety. Methods A retrospective analysis of 218 cases of patients with BPH urology, including the control group 75 patients given tamsulosin release capsules; patients treated with 143 cases in the control group based on the use epristeride films, and recorded two symptoms changing circumstances and adverse reactions. Results Three months later two groups of patients symptoms improved significantly in the treatment group to improve the condition of the indicators are bet er than the control group, there were significant difference statistical y significant. Conclusion Tamsulosin alone treatment of benign prostatic hyperplasia safe and effective, tamsulosin combination therapy with epristeride can quickly relieve symptoms, the clinical ef ect will be more obvious.

关键词

坦洛新/爱普列特/良性前列腺增生症

Key words

Tamsulosin/Epristeride/Benign prostatic hyperplasia

引用本文复制引用

张昊..坦洛新联合爱普列特治疗良性前列腺增生症的临床观察[J].医学信息,2014,(20):239-239,1.

医学信息

1006-1959

访问量0
|
下载量0
段落导航相关论文